Literature DB >> 18831926

Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells.

M Orciani1, M Emanuelli, C Martino, A Pugnaloni, A L Tranquilli, R Di Primio.   

Abstract

In recent years, the use of stem cells has generated increasing interest in regenerative medicine and cancer therapies. The most potent stem cells derive from the inner cell mass during embryonic development and their use yields serious ethical and methodological problems. Recently, a number of reports suggests that another suitable source of multipotent stem cells may be the amniotic fluid. Amniotic fluid mesenchymal stem cells (AFMSCs) are capable of extensive self-renewal, able to differentiate in specialized cells representative of all three germ layers, do not show ethical restriction, and display minimal risks of teratomas and a very low immunogenity. For all these reasons, amniotic fluid appears as a promising alternative source for stem cell therapy. Their recent discovery implies a lack of knowledge of their specific features as well as the existence of a protocol universally recognized as the most suitable for their isolation, growth and long-term conservation. In this study, we isolated stem cells from six amniotic fluids; these cells were cultured with three different culture mediums (Mesenchymal Stem Cell Medium (MSCGM), PC-1 and RPMI-1640), characterized by cytofluorimetric analysis, and then either frozen or induced to neuronal differentiation. Even if the immunophenotype seemed not to be influenced by culture medium (all six samples cultured in the above-mentioned mediums expressed surface antigens commonly found on stem cells), cells showed different abilities to differentiate into neuron-like cells and to re-start the culture after short/long-term storage. Cells isolated and cultured in MSCGM showed the highest proliferation rate, and formed neuron-like cells when sub-plated with neuronal differentiation medium. Cells from PC-1, on the contrary, displayed an increased ability to re-start culture after short/long term storage. Finally, cells from RPMI-1640, even if expressing stem cells markers, were not able to differentiate in neuron-like cells. Further studies are still needed in order to assess the effective role of culture medium for a successful isolation, growth, differentiation and storage of AFMSCs, but our data underline the importance of finding a universally accepted protocol for the use of these cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18831926     DOI: 10.1177/039463200802100312

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  12 in total

1.  Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.

Authors:  Peter V Hauser; Roberta De Fazio; Stefania Bruno; Simona Sdei; Cristina Grange; Benedetta Bussolati; Chiara Benedetto; Giovanni Camussi
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  New miRNAs network in human mesenchymal stem cells derived from skin and amniotic fluid.

Authors:  R Lazzarini; G Sorgentoni; M Caffarini; M A Sayeed; F Olivieri; R Di Primio; M Orciani
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

3.  Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas.

Authors:  Monia Orciani; Miriam Caffarini; Giulia Sorgentoni; Riccardo Antonio Ricciuti; Giorgio Arnaldi; Roberto Di Primio
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

4.  Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.

Authors:  M Orciani; S Davis; G Appolloni; R Lazzarini; M Mattioli-Belmonte; R A Ricciuti; M Boscaro; R Di Primio; G Arnaldi
Journal:  Cancer Gene Ther       Date:  2014-12-19       Impact factor: 5.987

5.  Bioartificial Kidneys.

Authors:  Peter R Corridon; In Kap Ko; James J Yoo; Anthony Atala
Journal:  Curr Stem Cell Rep       Date:  2017-04-12

Review 6.  Amniotic fluid stem cells to study mTOR signaling in differentiation.

Authors:  Margit Rosner; Katharina Schipany; Bharanidharan Shanmugasundaram; Gert Lubec; Oliver Brandau; Markus Hengstschläger
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

Review 7.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

8.  Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection Procedure.

Authors:  S Arnhold; S Glüer; K Hartmann; O Raabe; K Addicks; S Wenisch; M Hoopmann
Journal:  Stem Cells Int       Date:  2011-02-23       Impact factor: 5.443

9.  Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis.

Authors:  Margit Rosner; Helmut Dolznig; Katharina Schipany; Mario Mikula; Oliver Brandau; Markus Hengstschläger
Journal:  Oncotarget       Date:  2011-09

10.  Amniotic fluid stem cells: future perspectives.

Authors:  Margit Rosner; Katharina Schipany; Bharanidharan Shanmugasundaram; Gert Lubec; Markus Hengstschläger
Journal:  Stem Cells Int       Date:  2012-06-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.